References
- GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJExecutive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clnical practice guidelinesChest20121417S47S22315257
- AbuDaggaAStephensonJJFuACKwongWJTanHWeintraubWSCharacteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysisBMC Health Serv Res20141431025034699
- BrownJDShewaleARTalbertJCAdherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillationJ Manag Care Spec Pharm2016221319132927783556
- ConnollySJEzekowitzMDYusufSDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med20093611139115119717844
- GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationN Engl J Med201136598199221870978
- PatelMRMahaffeyKWGargJRivaroxaban versus warfarin in nonvalvular atrial fibrillationN Engl J Med201136588389121830957
- FangMCGoASChangYA new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyJ Am Coll Cardiol20115839540121757117
- GallagherAMRietbrockSPlumbJvan StaaTPInitiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?J Thromb Haemost200861500150618573187
- MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Bimingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet200737049350317693178
- McHorneyCACriveraCLaliberteFAdherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measureCurr Med Res Opin2015312167217326393483
- ZalesakMSiuKFrancisKHigher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarinCirc Cardiovasc Qual Outcomes2013656757423922182
- MartinezCKatholingAWallenhorstCFreedmanSBTherapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOACThromb Haemost2015115313926246112
- DavisNJBilletHHCohenHWAmstenJHImpact of adherence, knowledge, and quality of life on anticoagulation controlAnn Pharmacother20053963263615713790
- DeitzelweigSBBuysmanEPinskyBWarfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care populationClin Ther2013351201121023867114
- HylekEMEvans-MolinaCSheaCHenaultLEReganSMajor hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillationCirculation20071152689269617515465
- CastellucciLAShawJvan der SalmKSelf-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scaleThromb Res201513672773126272305
- OsterbergLBlaschkeTAdherence to medicationN Engl J Med200535348749716079372
- PatelSICheringtonCScherberRAssessment of patient adherence to direct oral anticoagulant vs warfarin therapyJ Am Osteopath Assoc201711771528055097
- ObamiroKOChalmersLBereznickiLRA summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillationAm J Cardiovasc Drugs20161634936327262433
- YaoXAbrahamNSAlexanderGCEffect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillationJ Am Heart Assoc201652 pii:e003074
- WasserTWBYcasJTunceliOApplying weighting methodologies to a commercial database to project US Census demographic dataAm J Accountable Care201593338
- MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)20081034835418453793
- GoASHylekEMChangYAnticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?JAMA20032902685269214645310
- DeyoRACherkinDCCoxMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol1992456136191607900
- GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA20012852864287011401607
- JoundiRACiprianoLESposatoLASaposnikGIschemic stroke risk in ptients with atrial fibrillation and CHA2DS2-VASc score of 1: systematic review and meta-analysisStroke2016471364136727026630
- GageBFYanYMilliganPEClinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)Am Heart J200615171371916504638
- SamsaGMatcharDBDolorRJA new instrument for measuring anticoagulation-related quality of life: development and preliminary validationHealth Qual Life Outcomes200422215132746
- AljumahKHassaliAAAlQhataniSExamining the relationship between adherence and satisfaction with antidepressant treatmentNeuropsychiatr Dis Treatment20141014331438
- HanonOChaussadeEGuerangerPGrusonEBonanSGayAPatient-reported treatment satisfaction with rivaroxaban for stroke prevention in atrial fibrillation. A French observational study, the SAFARI StudyPLoS One201611e016621827935987
- MuellerSMeineckeA-KBuchwaldSEirikssonDWilkeTDoes treatment satisfaction influence adherence to treatment? Impact of AF patients’ treatment satisfaction on adherence to oral anticoagulation treatmentASH 59th Annual Meeting & ExpositionDecember 9–12, 2017Atlanta, GA2017
- ZyoudSAl-JabiSWSweilehWMMoriskyDERelationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in PalestineHealth Qual Life Outcomes20131119124195638
- BarbosaCDBalpM-MKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePat Pref Adherence201263948
- Almeida GdeQNoblat LdeAPassosLCdo NascimentoHFQuality of life analysis of patients in chronic use of oral anticoagulant: an observational studyHealth Qual Life Outcomes201199122027368
- PotparaTSLaneDALipGYOptimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomesEuropace20151750750825833879
- Mas DalmauGSant ArderiuEEnfedaque MontesMBSolaIPequeno SacoSAlonso CoelloPPatients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic reviewBMC Fam Pract201718328086887
- LipGYNieuwlaatRPistersRLaneDACrijnsHJRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial FibrillationChest201013726327219762550